AU2863899A - New compounds - Google Patents

New compounds

Info

Publication number
AU2863899A
AU2863899A AU28638/99A AU2863899A AU2863899A AU 2863899 A AU2863899 A AU 2863899A AU 28638/99 A AU28638/99 A AU 28638/99A AU 2863899 A AU2863899 A AU 2863899A AU 2863899 A AU2863899 A AU 2863899A
Authority
AU
Australia
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28638/99A
Inventor
Kostas Karabelas
Hans Lonn
Peter Sjo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU2863899A publication Critical patent/AU2863899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
AU28638/99A 1998-03-13 1999-02-26 New compounds Abandoned AU2863899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9800836A SE9800836D0 (en) 1998-03-13 1998-03-13 New Compounds
SE9800836 1998-03-13
PCT/SE1999/000276 WO1999046260A1 (en) 1998-03-13 1999-02-26 New compounds

Publications (1)

Publication Number Publication Date
AU2863899A true AU2863899A (en) 1999-09-27

Family

ID=20410540

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28638/99A Abandoned AU2863899A (en) 1998-03-13 1999-02-26 New compounds

Country Status (3)

Country Link
AU (1) AU2863899A (en)
SE (1) SE9800836D0 (en)
WO (1) WO1999046260A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114524805A (en) * 2022-03-10 2022-05-24 浙江树人学院（浙江树人大学） Application of solid acid catalysis multi-component reaction in preparation of fluorine-containing medicine

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
DE60221391T2 (en) 2001-06-20 2008-04-17 Wyeth SUBSTITUTED INDOLESE DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
ES2325071T3 (en) 2002-12-10 2009-08-25 Wyeth DERIVATIVES OF INDOL-OXO-ACETILAMINOACETIC ACID REPLACED AS INHIBITORS OF THE PLASMINOGEN-1 ACTIVATOR INHIBITOR (PAI-1).
CN1726190A (en) 2002-12-10 2006-01-25 惠氏公司 Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
JP2006514640A (en) 2002-12-10 2006-05-11 ワイス Substituted 3-alkyl and 3-arylalkyl 1H-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitors
ATE411288T1 (en) 2002-12-10 2008-10-15 Wyeth Corp ARYL-, ARYLOXY- AND ALKYLOXY-SUBSTITUTED 1H-INDOLE-3-YL-GLYOXYLIC ACID DERIVATIVES INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US20070105851A1 (en) * 2003-11-21 2007-05-10 Bayer Pharmaceuticals Corporation Indolyl-thienopyrazinone derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis
AU2004313246A1 (en) * 2004-01-06 2005-07-28 Janssen Pharmaceutica, N.V. (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
CA2577857A1 (en) 2004-08-23 2006-03-02 Wyeth Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
CN101263115A (en) 2005-08-17 2008-09-10 惠氏公司 Substituted indoles and use thereof
AR066879A1 (en) 2007-06-08 2009-09-16 Novartis Ag DERIVATIVES OF QUINOXALINE AS INHIBITORS OF THE TYPOSINE CINASA ACTIVITY OF THE JANUS CINASES
WO2009027820A2 (en) 2007-08-31 2009-03-05 Purdue Pharma L.P. Substituted-quinoxaline-type-piperidine compounds and the uses thereof
PT2247292T (en) 2008-03-05 2017-07-17 Merck Patent Gmbh Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
AR072578A1 (en) 2008-07-21 2010-09-08 Purdue Pharma Lp COMPOSED PIPERIDINE BRIDGES REPLACED TYPE QUINOXALINE AND USES OF THE SAME
US20100113461A1 (en) 2008-10-29 2010-05-06 Gilead Palo Alto, Inc. Substituted heterocyclic compounds
US20100113514A1 (en) 2008-10-30 2010-05-06 Gilead Palo Alto, Inc. Fused heterocyclic compounds as ion channel modulators
JP5872585B2 (en) 2010-12-22 2016-03-01 パーデュー、ファーマ、リミテッド、パートナーシップ Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
WO2013080036A1 (en) 2011-12-01 2013-06-06 Purdue Pharma L.P. Azetidine-substituted quinoxaline-type piperidine compounds and uses thereof
US9085561B2 (en) 2012-07-30 2015-07-21 Purdue Pharma L.P. Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators
WO2014102592A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
WO2014102589A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW472045B (en) * 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114524805A (en) * 2022-03-10 2022-05-24 浙江树人学院（浙江树人大学） Application of solid acid catalysis multi-component reaction in preparation of fluorine-containing medicine
CN114524805B (en) * 2022-03-10 2023-01-24 浙江树人学院（浙江树人大学） Application of solid acid catalysis multi-component reaction in preparation of fluorine-containing medicine

Also Published As

Publication number Publication date
SE9800836D0 (en) 1998-03-13
WO1999046260A1 (en) 1999-09-16

Similar Documents

Publication Publication Date Title
AU2863899A (en) New compounds
AU4580599A (en) Stable no-delivering compounds
AUPP796798A0 (en) New compound
AU732211C (en) Novel compound
AU4260199A (en) Novel compounds
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU2014800A (en) Novel compounds
AU5980899A (en) Novel compounds
AU1434500A (en) Compounds
AU4814699A (en) Novel compounds
AUPP549998A0 (en) New compound
AU5516599A (en) Substituted 3-aryl-pyrazoles
AU2187799A (en) Novel taxaneterpine compounds
AU5998199A (en) New bis-benzimidazoles
AU4511499A (en) Substituted cyclooctadepsipeptides
AU2863799A (en) New compounds
AU4507899A (en) Substituted n-aryl-o-alkyl-carbamates
AU1055399A (en) Rollerboard
AU2725599A (en) Substituted alxoxycarbonyl compounds
AU5661399A (en) Compounds
AU1192300A (en) Novel compounds
AUPP377198A0 (en) Novel compound WF00144
AU3715899A (en) Di-peroxy compounds
AUPP172898A0 (en) New compound

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase